Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Ameratunga

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|October 14, 2014
Comparison of diagnostic criteria for common variable immunodeficiency disorderRohan Ameratunga, Maia Brewerton, Charlotte Slade, et al.
Frontiers in Immunology|February 14, 2018
Clinical Implications of Digenic Inheritance and Epistasis in Primary Immunodeficiency DisordersRohan Ameratunga, See-Tarn Woon, Vanessa L Bryant, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Journal of Clinical Immunology|August 31, 2015
Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing EnteropathyRohan Ameratunga, Russell William Barker, Richard Henderson Steele, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 14, 2013
Diagnostic utility of modified gliadin peptide antibody assays in New Zealand childrenBenjamin C Hope, Rohan Ameratunga, Paul M Austin, et al.
The New Zealand Medical Journal|April 9, 2008
The changing epidemiology of food allergy--implications for New ZealandChristine Crooks, Rohan Ameratunga, Greg Simmons, et al.
Antiviral Research|April 27, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, et al.
Pathology|November 16, 2023
Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotypingSee-Tarn Woon, Felicia Tjandra, John Mackay, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Frontiers in Immunology|February 4, 2022
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised PatientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|October 14, 2014
Comparison of diagnostic criteria for common variable immunodeficiency disorderRohan Ameratunga, Maia Brewerton, Charlotte Slade, et al.
Frontiers in Immunology|February 14, 2018
Clinical Implications of Digenic Inheritance and Epistasis in Primary Immunodeficiency DisordersRohan Ameratunga, See-Tarn Woon, Vanessa L Bryant, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Journal of Clinical Immunology|August 31, 2015
Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing EnteropathyRohan Ameratunga, Russell William Barker, Richard Henderson Steele, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 14, 2013
Diagnostic utility of modified gliadin peptide antibody assays in New Zealand childrenBenjamin C Hope, Rohan Ameratunga, Paul M Austin, et al.
The New Zealand Medical Journal|April 9, 2008
The changing epidemiology of food allergy--implications for New ZealandChristine Crooks, Rohan Ameratunga, Greg Simmons, et al.
Antiviral Research|April 27, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, et al.
Pathology|November 16, 2023
Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotypingSee-Tarn Woon, Felicia Tjandra, John Mackay, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Frontiers in Immunology|February 4, 2022
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised PatientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Pageof 10